[EVXBTC] Everex After Accumulation [555% PP]
Updated
We have a pretty straight forward chart for Everex (EVXBTC). Let’s take a look:
- MACD Bullish crossover.
- Increasing volume. Highest volume in several months.
- STOCH oversold. Low RSI. Room available for growth.
Trade instructions for Everex (EVXBTC)
Buy in: 0.0000653 – 0.0000711
Targets for EVXBTC by Alan Masters:
(1) 0.0000843
(2) 0.0000916
(3) 0.0001010
(4) 0.0001231
Stop loss: Close weekly below 0.00005638.
Capital allocation: <5%.
Thanks a lot for your continued support.
Have an amazing day/week/weekend.
Namaste.
- MACD Bullish crossover.
- Increasing volume. Highest volume in several months.
- STOCH oversold. Low RSI. Room available for growth.
Trade instructions for Everex (EVXBTC)
Buy in: 0.0000653 – 0.0000711
Targets for EVXBTC by Alan Masters:
(1) 0.0000843
(2) 0.0000916
(3) 0.0001010
(4) 0.0001231
Stop loss: Close weekly below 0.00005638.
Capital allocation: <5%.
Thanks a lot for your continued support.
Have an amazing day/week/weekend.
Namaste.
Trade active
We are above our buy in range and moving into the positive.First target: 0.0000843.
Trade closed: target reached
ALL TARGETS REACHED.Over 200% earnings (100% profits) from buy in to peak reached.
Targets for EVXBTC by Alan Masters:
(1) 0.0000843 * Target hit 6-Oct. *
(2) 0.0000916 * Target hit 6-Oct. *
(3) 0.0001010 * Target hit 6-Oct. *
(4) 0.0001231 * Target hit 6-Oct. *
Enjoy the profits.
Stay tuned for many more amazing and very profitable trades.
If you enjoyed this trade, please like, share, comment and follow.
Your support is highly appreciated.
Namaste.
🔝 The Greatest Cryptocurrency Analysis on Earth!
followalan.com
🔥 6-In-1 ULTIMATE Package Offer Now Live! (The Best In The Market)
lamatrades.com (Since 2017)
🚨 The Best Trade-Numbers In The Universe
alansantanatrades.com
followalan.com
🔥 6-In-1 ULTIMATE Package Offer Now Live! (The Best In The Market)
lamatrades.com (Since 2017)
🚨 The Best Trade-Numbers In The Universe
alansantanatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.